【TTA x CES2023】Cell technology and Diagnostic/CDMO application platforms – CytoAurora

CES 2023 Innovation AwardCytoAurora

CytoAurora is a biotechnology company focused on developing Cell technology and Diagnostic/CDMO application platforms. Our team consist of expertise from Biomedical sciences, Electronics engineers, Automation engineers and Semiconductor process engineers and make the best of cross-field integration. (For more information in detail, please visit the official website: https://www.cytoaurora.com/home)

 

醫華生醫的成立的使命,是利用生醫技術幫助與回饋社會,目標就是應用研發的創新細胞生物技術,例如分析CTC與基因變異,不但能針對癌症早期發現、早期治療、協助醫師提高癌症治療存活率,且利用其「液體活檢」技術搭配自行研發的「半導體生醫晶片」、「A.I人工智能輔助判斷」等技術,不但可偵測血液中稀有目標細胞,且能應用於基因與蛋白質研究。(了解更多公司訊息請參考官方網站: https://www.cytoaurora.com/)

發表評論